Society for Clinical Research Sites Welcomes New Global Impact Partner


Applied Clinical Trials

ELLICOTT CITY, Md., March 30, 2015 – The Society for Clinical Research Sites (SCRS), the global trade organization fully dedicated to representing the interests of clinical research sites, today announced a two-year partnership with PRA Health Sciences (PRA), a leading CRO. PRA will participate as a Global Impact Partner (GIP), a relationship which exemplifies PRA’s commitment to promoting greater site sustainability for clinical research sites globally.

“PRA’s commitment to become a GIP is indicative of their eagerness to initiate and maintain positive site relationships; we are pleased they have selected SCRS as the catalyst,” commented Christine Pierre, SCRS President. “Collaboration with PRA is a significant strategic development for SCRS, and we are proud to welcome them as our newest GIP.”

“PRA is excited to join SCRS as a Global Impact Partner,” said Michael Brooks, PRA Senior Vice President and Head, Product Registration Americas. “PRA looks forward to maintaining a close engagement with the clinical research site community and, in partnership with SCRS, developing innovations and best practices to accelerate the development of new therapies for patients around the world.”

As a Global Impact Partner (GIP), PRA Health Sciences will participate on the SCRS Global Impact Board at an executive level, and work closely with SCRS’ Leadership Council in the development and execution of strategic initiatives for SCRS.


Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.